Researcher
Hans Van Vlierberghe
- Keywords:liver transplantation, hepatocellular carcinoma, liver diseases
- Disciplines:Cancer diagnosis, Cancer prevention, Cancer epidemiology, Cancer biology, Cancer therapy, Gastro-enterology and hepatology not elsewhere classified, Hepatology (incl. pancreas), Oncology not elsewhere classified, Gastro-enterology, Hepatology
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Oct 2003 → 30 Sep 2018
Projects
1 - 10 of 19
- Development of cell-interactive and biodegradable AUP-based hydrogel materials for the fabrication of three-dimensional liver tissue engineering scaffoldsFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Optimising the Human Detection of Cancer within Colorectal Polyps with a Simple Clinical AlgorithmFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Deubiquitinase UCHL1 targeting as part of new combinatorial treatments for hepatocellular carcinoma: a preclinical assessmentFrom1 Oct 2022 → TodayFunding: Nonprofit institution or equivalents
- SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomicsFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- The role of Kupffer cells in the pathogenesis of hepatocellular carcinoma.From1 Nov 2021 → 31 Oct 2022Funding: Nonprofit institution or equivalents
- Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitisFrom1 Nov 2021 → TodayFunding: FWO fellowships
- Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitis.From1 Oct 2021 → 31 Oct 2021Funding: BOF - doctoral mandates
- Dual targeting of CCr2 and CCR5 as thearpy for hepatocellular carcinoma: can we break immune tolerance?From1 Oct 2018 → 30 Sep 2022Funding: Nonprofit institution or equivalents
- Replacement of N-glycan analysis equipmentFrom1 Jun 2018 → 31 May 2020Funding: BOF - Other initiatives
- Startersbeurs Helena Degroote: The origin of tumor-associated macrophages and the therapeutic potential of dual targeting CCR2 and CCR5 as therapy for hepatocellular carcinomaFrom1 Oct 2017 → 30 Sep 2018Funding: Nonprofit institution or equivalents
Publications
31 - 40 of 103
- Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib(2016)
Authors: Lorenza Rimassa, Giovanni Abbadessa, Nicola Personeni, Camillo Porta, Ivan Borbath, Bruno Daniele, Stefania Salvagni, Jean-Luc Van Laethem, Hans Van Vlierberghe, Jörg Trojan, et al.
Pages: 72622 - 72633 - Cirrhosis : reviewing the literature and future perspectives(2016)
Authors: Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe
Pages: 111 - 117 - Targeting the angio-proteostasis network : combining the forces against cancer(2016)
Authors: Lindsey Devisscher, Margherita Vieri, Susan E. Logue, Jens Panse, Anja Geerts, Hans Van Vlierberghe, Eric Chevet, Adrienne M. Gorman, Afshin Samali, Behzad Kharabi Masouleh
Pages: 1 - 12 - Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results(2015)Volume: 78
Authors: Delphine Degré, Wim Laleman, Xavier Verhelst, Anne Lamproye, Thomas Vanwolleghem, Thierry Gustot, Peter Starkel, Nicolas Lanthier, Peter Michielsen, Jean Delwaide, et al.
Number of pages: 1 - Multicenter Belgian experience of sofosbuvir medical need program in pre- and post liver transplantation patients : safety and efficacy results(2015)Volume: 28
Authors: Delphine Degre, Wim Laleman, Xavier Verhelst, Anne Lamproye, Thomas Vanwolleghem, Thierry Gustot, Peter Starkel, Nicolas Lanthier, Peter Michielsen, Jean Delwaide, et al.
Pages: 21 - 21 - Late liver retransplantation with deceased and living donor liver grafts: a comparative single institution analysis(2014)Volume: 27
Authors: Veronica Scuderi, Federico Tomassini, Alice Nigro, MAURICIO SAINZ-BARRIGA, Isabelle Colle, Hans Van Vlierberghe, Roberto Troisi
Pages: 9 - 10 - Living donor versus deceased donor liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF and Asan criteria: long-term follow-up(2014)Volume: 20
Authors: Italo Bonadio, Isabelle Colle, Anja Geerts, Peter Smeets, Marleen Praet, Giammauro Berardi, Bernard de Hemptinne, Hans Van Vlierberghe, Roberto Troisi
Pages: S249 - S249 - Characteristics, treatment, and virologic responses of chronic hepatitis C patients treated with peginterferon alfa-2a and ribavirin in Belgium : a sub-analysis of the PROPHESYS study(2014)
Authors: J. P. Mulkay, S. Bourgeois, L. Lasser, C. De Galocsy, S. Tomasovic, Y. Horsmans, Hans Van Vlierberghe
Pages: 30 - 40 - Significance of initial poor function after liver transplantation(2014)Volume: 60
Authors: Thamara Perera, Jan Colpaert, Hans Van Vlierberghe, Roberto Troisi, Xavier Rogiers, Darius Mirza
Pages: 373A - 373A - The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota(2014)
Authors: Maria L Balmer, Emma Slack, Andrea de Gottardi, Melissa AE Lawson, Siegfried Hapfelmeier, Luca Miele, Antonio Grieco, Hans Van Vlierberghe, Rene Fahrner, Nicola Patuto, et al.